Edgewise Therapeutics, Inc. (EWTX) Capital expenditures 2020–2025
Edgewise Therapeutics, Inc. (EWTX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$256,000FY2025 · since FY2020: $203,000 → $256,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $256,000 | -80.5% |
| FY2024 | $1.3M | -77.2% |
| FY2023 | $5.7M | +3.6% |
| FY2022 | $5.5M | +730.2% |
| FY2021 | $668,000 | +229.1% |
| FY2020 | $203,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice